by Eric Christianson | Jun 2, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Osteoarthritis is one of the most common pain syndromes in the aging adult. Medications are often used to reduce pain and increase quality of life. In this article, I will review osteoarthritis pharmacotherapy and discuss some of my most important practice pearls....
by Eric Christianson | May 26, 2024 | Pediatrics Medication and Disease State Clinical Pearls
Can you answer these questions on our pediatric crossword puzzle? Pediatrics is always an important topic for anyone taking the NAPLEX, BCPS, or other board exams. Here are some of the most highly testable clinical practice pearls in the topic of pediatrics. Answers...
by Eric Christianson | May 22, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
I have many patients who take garlic supplements. One of the interactions I remember learning in pharmacy school is that garlic has the potential to increase the risk of bleeding when taken in combination with blood-thinning medications such as warfarin, DOACs,...
by Eric Christianson | May 19, 2024 | Cardiovascular Medication and Disease State Clinical Pearls
Thiazide diuretics are commonly are one of the most commonly used classes of antihypertensive agents. They carry many adverse effects. Some can be a nuisance while others can be more serious. In this blog post, I’ll run down the most common thiazide diuretic...
by Eric Christianson | May 15, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Antibiotics are an essential tool to treat infections. I’ve seen a lot of drug interactions involving antibiotics that have led to anything from treatment failure to drug toxicity. In this blog post, I share my top 5 antibiotic drug interactions you are likely...
by Eric Christianson | May 12, 2024 | Clinical Pharmacy News and New Drug Updates, Gastrointestinal Medication and Disease State Clinical Pearls
On November 1, 2023, the U.S. Food and Drug Administration (FDA) approved VOQUEZNA® (vonoprazan) as a new treatment for the healing and maintenance of erosive esophagitis and the relief of heartburn associated with erosive esophagitis in adults. This FDA approval...
